Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0289-2021Class II

Merge LIS

Merge Healthcare Incorporated / initiated 2017-01-23 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of Merge LIS on . FDA classified it as Class II and gives the reason as "A defect in the software resulted in medications that are not associated with the patient (i.e., medications that the patient is not currently taking) appearing on their report". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0289-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
Merge LIS
Product code
NSX
Reason for recall
A defect in the software resulted in medications that are not associated with the patient (i.e., medications that the patient is not currently taking) appearing on their report.
Root cause tag
software
FDA root cause
Software design
Action
A defect in the software resulted in medications that are not associated with the patient (i.e., medications that the patient is not currently taking) appearing on their report.
Quantity in commerce
47 units
Distribution
Domestic Distribution Only: Alabama, California, Colorado, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Michigan, Mississippi, Oklahoma, Tennessee, Texas.
Product codes and lots
Merge LIS versions 4.0.1, 4.1, 4.1.1, 4.1.2, 4.1.3, 4.1.4, 4.1.5, 4.1.5 Patch 1, and 4.1.5 Patch 2

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0289-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0289-2021Class IITerminatedVoluntary: Firm initiated